Morbidity of the Abdominal Wall Resection and Reconstruction After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

被引：0
|
作者：
Maria F. Nunez
Armando Sardi
Carol Nieroda
William Jimenez
Michelle Sittig
Ryan MacDonald
Nail Aydin
Vladimir Milovanov
Vadim Gushchin
机构：
[1] Institute for Cancer Care at Mercy Medical Center,
来源：
Annals of Surgical Oncology | 2015年 / 22卷
关键词：
Peritoneal Carcinomatosis; Wound Complication; Port Site; Peritoneal Cancer Index; Complete Cytoreduction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：1658 / 1663
页数：5
相关论文
共 50 条
  • [31] Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
    Vassos, Nikolaos
    Foertsch, Thomas
    Aladashvili, Archil
    Hohenberger, Werner
    Croner, Roland S.
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
  • [32] Prehabilitation of patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancy
    Cortes-Guiral, Delia
    Mohamed, Faheez
    Glehen, Olivier
    Passot, Guillaume
    EJSO, 2021, 47 (01): : 60 - 64
  • [33] Impact of insurance status on overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)
    Chokshi, Ravi J.
    Kim, Jin K.
    Patel, Jimmy
    Oliver, Joseph B.
    Mahmoud, Omar
    PLEURA AND PERITONEUM, 2020, 5 (03)
  • [34] Appendiceal Goblet Cell Carcinoma: Role of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    M. Gaillard
    P. Van Eyken
    G. Verswijvel
    K. Van der Speeten
    Indian Journal of Surgical Oncology, 2023, 14 : 240 - 249
  • [35] Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
    Nikolaos Vassos
    Thomas Förtsch
    Archil Aladashvili
    Werner Hohenberger
    Roland S. Croner
    World Journal of Surgical Oncology, 14
  • [36] Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): a Single-Center Experience in Austria
    Kogler Pamela
    Zitt Matthias
    Kafka-Ritsch Reinhold
    Punter Julia
    Müssigang Peter
    Perathoner Alexander
    Öfner Dietmar
    Journal of Gastrointestinal Surgery, 2018, 22 : 884 - 893
  • [37] Factors affecting dietary progression post cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Stibbard, Allysha
    Brown, Morgan
    Pons, Rachel
    Ward, Jessica
    Page, Naomi
    Stefoska-Needham, Anita
    CLINICAL NUTRITION ESPEN, 2024, 63 : 520 - 529
  • [38] RESULTS OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) WITH SIMULTANEOUS COMPLEX RECONSTRUCTION OF THE ABDOMINAL WALL
    Anton Fernandez, Ismael
    Loro Perez, Jorge
    Gonzalez Sanchez, Laura
    Lopez Tomasety, Eudaldo
    Hernandez Hernandez, JuanRamon
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [39] Morbidity and mortality of elderly patients following cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    Wong, Evelyn Y. T.
    Tan, Grace H. C.
    Chia, Claramae S. L.
    Kumar, Mrinal
    Soo, Khee Chee
    Teo, Melissa C. C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (02) : E193 - E202
  • [40] Preliminary Experience and Morbidity Analysis of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/Hipec) from a Tertiary Cancer Center in India
    Padmanabhan, Naveen
    Kumar, Barath Raj
    Pookunju, Ansar Pullampara
    Srinivasan, Ayvapan
    Mahajan, Vikash
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (06) : XC9 - XC13
12345